| Product NDC: | 16590-254 |
| Proprietary Name: | Megace ES |
| Non Proprietary Name: | MEGESTROL ACETATE |
| Active Ingredient(s): | 125 mg/mL & nbsp; MEGESTROL ACETATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-254 |
| Labeler Name: | Stat Rx USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021778 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050608 |
| Package NDC: | 16590-254-33 |
| Package Description: | 150 mL in 1 BOTTLE (16590-254-33) |
| NDC Code | 16590-254-33 |
| Proprietary Name | Megace ES |
| Package Description | 150 mL in 1 BOTTLE (16590-254-33) |
| Product NDC | 16590-254 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MEGESTROL ACETATE |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20050608 |
| Marketing Category Name | NDA |
| Labeler Name | Stat Rx USA |
| Substance Name | MEGESTROL ACETATE |
| Strength Number | 125 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |